CV — CapsoVision Income Statement
0.000.00%
Last trade - 00:00- $178.93m
- $318.15m
- $11.76m
Annual income statement for CapsoVision, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 9.75 | 11.8 |
| Cost of Revenue | ||
| Gross Profit | 5.49 | 6.38 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Total Operating Expenses | 21.1 | 31.7 |
| Operating Profit | -11.3 | -19.9 |
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -11.3 | -19.9 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -11.3 | -19.9 |
| Net Income Before Extraordinary Items | ||
| Net Income | -11.3 | -19.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -11.3 | -19.9 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.244 | -0.429 |
| Dividends per Share |